ClinVar Miner

Submissions for variant NM_001005373.4(LRSAM1):c.2093_2104del (p.Gln698_Gln701del)

dbSNP: rs1554763017
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000531303 SCV000652031 pathogenic Charcot-Marie-Tooth disease axonal type 2P 2023-11-24 criteria provided, single submitter clinical testing This variant, c.2093_2104del, results in the deletion of 4 amino acid(s) of the LRSAM1 protein (p.Gln698_Gln701del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with autosomal dominant Charcot-Marie-Tooth disease (PMID: 30996334). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 472799). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. For these reasons, this variant has been classified as Pathogenic.
Ambry Genetics RCV002420507 SCV002725041 pathogenic Inborn genetic diseases 2021-12-22 criteria provided, single submitter clinical testing The c.2093_2104del12 pathogenic mutation (also known as p.Q698_Q701del) is located in coding exon 24 of the LRSAM1 gene. This variant results from an in-frame AGTGCTGCCAGC deletion at nucleotide positions 2093 to 2104. This results in the in-frame deletion of QCCQ from codons 698 to 701. This alteration was detected in the heterozygous state in multiple individuals with autosomal dominant Charcot-Marie-Tooth disease 2, and it was found to segregate with disease in multiple families originating from western and southwestern France (Peretti A et al. Eur J Hum Genet, 2019 09;27:1406-1418). This amino acid region is well conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). Based on the supporting evidence, this variant is expected to be causative of autosomal dominant Charcot-Marie-Tooth disease, type 2P (CMT2P); however, its clinical significance for autosomal recessive CMT2P is unclear.
Biochimie - Maladies Neurologiques Hereditaires, Hospices Civils de Lyon RCV000531303 SCV000839589 pathogenic Charcot-Marie-Tooth disease axonal type 2P 2018-06-29 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.